.Sanofi has actually brought in a late entrance to the radioligand celebration, paying for 100 thous...
.After F2G's initial effort to get a new training class of antifungal to market was thwarted due to ...
.Moderna has actually promised to reduce R&D spending by $1.1 billion through 2027. The choice to...
.Merely four months after Sanofi wager $80 thousand in beforehand cash on Fulcrum Therapies' losmapi...
.Cancer business Oncternal Therapies is folding all its own scientific tests and also giving up team...
.Roche is actually keeping out chances that its own injectable weight problems prospect might eventu...
.Novo Nordisk has actually elevated the top on a stage 1 trial of its own oral amylin and also GLP-1...
.Simply a handful of brief full weeks after gaining an FDA Fast Track tag for its own investigationa...
.Not long after a positive data decline for Eli Lilly's efsitora alfa, the Indianapolis-based compan...
.BridgeBio Pharma is slashing its own gene therapy budget plan and also drawing back from the method...